Cargando…

Shortcomings in Pharmacy Benefit Forecasting - Interferon Beta Products

Detalles Bibliográficos
Autor principal: Rich, Sheldon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437280/
https://www.ncbi.nlm.nih.gov/pubmed/14613461
http://dx.doi.org/10.18553/jmcp.2003.9.4.373
_version_ 1785092482449539072
author Rich, Sheldon
author_facet Rich, Sheldon
author_sort Rich, Sheldon
collection PubMed
description
format Online
Article
Text
id pubmed-10437280
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher Academy of Managed Care Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-104372802023-08-21 Shortcomings in Pharmacy Benefit Forecasting - Interferon Beta Products Rich, Sheldon J Manag Care Pharm Letters Academy of Managed Care Pharmacy 2003-07 /pmc/articles/PMC10437280/ /pubmed/14613461 http://dx.doi.org/10.18553/jmcp.2003.9.4.373 Text en Copyright © 2003, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Letters
Rich, Sheldon
Shortcomings in Pharmacy Benefit Forecasting - Interferon Beta Products
title Shortcomings in Pharmacy Benefit Forecasting - Interferon Beta Products
title_full Shortcomings in Pharmacy Benefit Forecasting - Interferon Beta Products
title_fullStr Shortcomings in Pharmacy Benefit Forecasting - Interferon Beta Products
title_full_unstemmed Shortcomings in Pharmacy Benefit Forecasting - Interferon Beta Products
title_short Shortcomings in Pharmacy Benefit Forecasting - Interferon Beta Products
title_sort shortcomings in pharmacy benefit forecasting - interferon beta products
topic Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437280/
https://www.ncbi.nlm.nih.gov/pubmed/14613461
http://dx.doi.org/10.18553/jmcp.2003.9.4.373
work_keys_str_mv AT richsheldon shortcomingsinpharmacybenefitforecastinginterferonbetaproducts